Approval · Notice of Compliance 19631 · 2017
TEVA-MYCOPHENOLATE: Notice of Compliance 19631
Issued August 8, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19631
- Date
- August 8, 2017
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Administrative: Product name change
- Canadian reference product
- CELLCEPT
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-MYCOPHENOLATE | Not yet assigned | — |
Medicinal ingredients
- MYCOPHENOLATE MOFETIL 500 MG per TAB
- MYCOPHENOLATE MOFETIL 250 MG per CAP